Skip to main content

Table 2 Baseline information and the duration from NAIs therapy to H7N9 virus-negative

From: Efficacy of oseltamivir-peramivir combination therapy compared to oseltamivir monotherapy for Influenza A (H7N9) infection: a retrospective study

Patients Characteristics O + P O P Value
All patients n = 39 n = 43  
Patients whose virus still positive till death n = 7 n = 5  
Study patients n = 32 n = 38  
  Age (years): mean (SD) 55.22(14.25) 60.21(14.89) 0.64
  No. of male (%) 22(68.75 %) 27(71.05 %) 1.00
  Time from symptom onset to NAIs administration (days):median (IQR) 7.00(4.25, 8.75) 5.00(4.00, 7.00) 0.52
  APACHE II score: mean(SD) 17.47(8.08) 20.82(8.17) 0.87
  Viral load(log10 /ul) at day 0: median(IQR) 3.30(2.91, 4.1) 3.29(2.70, 4.47) 0.12
  Duration from NAIs taken to H7N9 virus negative(days): median(IQR) 7.00(6.00, 9.75) 6.50(4.00, 8.00) 0.67
  1. O oseltamivir monotherapy, O+P oseltamivir-peramivir combination therapy, IQR interquartile range, percentile 25 – percentile75